Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial (Q64112043)
Jump to navigation
Jump to search
scientific article published on 01 July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial |
scientific article published on 01 July 2002 |
Statements
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial (English)
T Cufer
P Bruning
R Coleman
L Duchateau
A H Calvert
T Gamucci
C Twelves
P Fargeot
R Epelbaum
C Lohrisch
M J Piccart